Trial Profile
Clinical study on Tolerability and pharmacokinetics of Albuvirtide injection in HIV-infected patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Labuvirtide (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 12 Sep 2012 Results presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 21 May 2012 Actual end date changed from May 2011 to Jul 2011 as reported by Chinese Clinical Trial Register record.
- 20 Sep 2011 New trial record